Bill Nygren - Harris Associates L P
Holding/activity history for HCA Healthcare Inc. (HCA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 158,143 | 0.10 | Reduce 12.65% | 0.01 | $473.24 | $74,839,593 | SEC |
| 2025 Q4 | 181,042 | 0.11 | Reduce 18.38% | 0.03 | $466.86 | $84,521,268 | SEC |
| 2025 Q3 | 221,822 | 0.15 | Reduce 8.41% | 0.01 | $426.20 | $94,540,536 | SEC |
| 2025 Q2 | 242,180 | 0.15 | Reduce 20.60% | 0.04 | $383.10 | $92,779,158 | SEC |
| 2025 Q1 | 305,031 | 0.18 | Reduce 4.57% | <0.01 | $345.55 | $105,403,462 | SEC |
| 2024 Q4 | 319,644 | 0.16 | Reduce 1.78% | <0.01 | $300.15 | $95,941,147 | SEC |
| 2024 Q3 | 325,437 | 0.22 | Reduce 12.52% | 0.03 | $406.43 | $132,267,360 | SEC |
| 2024 Q2 | 372,013 | 0.20 | Reduce 32.15% | 0.10 | $321.28 | $119,520,337 | SEC |
| 2024 Q1 | 548,266 | 0.30 | Reduce 75.29% | 0.78 | $333.53 | $182,863,159 | SEC |
| 2023 Q4 | 2,218,381 | 1.03 | Add 11.79% | 0.11 | $270.68 | $600,471,366 | SEC |
| 2023 Q3 | 1,984,345 | 0.95 | Reduce 34.15% | 0.59 | $245.98 | $488,109,241 | SEC |
| 2023 Q2 | 3,013,323 | 1.72 | Reduce 38.99% | 0.99 | $303.48 | $914,483,230 | SEC |
| 2023 Q1 | 4,938,692 | 2.53 | Reduce 25.97% | 0.85 | $263.68 | $1,302,234,354 | SEC |
| 2022 Q4 | 6,670,965 | 3.26 | Reduce 11.57% | 0.35 | $239.96 | $1,600,764,846 | SEC |
| 2022 Q3 | 7,543,460 | 3.00 | Reduce 2.61% | 0.07 | $183.79 | $1,386,413,000 | SEC |
| 2022 Q2 | 7,745,529 | 2.59 | Add 1.29% | 0.03 | $168.06 | $1,301,714,000 | SEC |
| 2022 Q1 | 7,646,769 | 3.08 | Reduce 2.60% | 0.08 | $250.62 | $1,916,433,000 | SEC |
| 2021 Q4 | 7,850,976 | 3.14 | Reduce 1.37% | 0.04 | $256.92 | $2,017,073,000 | SEC |
| 2021 Q3 | 7,959,746 | 3.08 | Reduce 9.44% | 0.27 | $242.72 | $1,931,989,000 | SEC |
| 2021 Q2 | 8,789,096 | 2.89 | Reduce 1.76% | 0.05 | $206.74 | $1,817,058,000 | SEC |
| 2021 Q1 | 8,946,718 | 2.88 | Reduce 0.75% | 0.02 | $188.34 | $1,685,025,000 | SEC |
| 2020 Q4 | 9,014,139 | 2.87 | Reduce 2.33% | 0.07 | $164.46 | $1,482,465,000 | SEC |
| 2020 Q3 | 9,229,275 | 2.80 | Add 15.05% | 0.37 | $124.68 | $1,150,706,000 | SEC |
| 2020 Q2 | 8,022,145 | 1.89 | Add 34.61% | 0.49 | $97.06 | $778,629,000 | SEC |
| 2020 Q1 | 5,959,728 | 1.48 | Add 4.82% | 0.07 | $89.85 | $535,482,000 | SEC |
| 2019 Q4 | 5,685,667 | 1.49 | Add 3.13% | 0.05 | $147.81 | $840,399,000 | SEC |
| 2019 Q3 | 5,513,094 | 1.29 | Add 4.11% | 0.05 | $120.42 | $663,886,000 | SEC |
| 2019 Q2 | 5,295,402 | 1.32 | Reduce 4.22% | 0.06 | $135.17 | $715,780,000 | SEC |
| 2019 Q1 | 5,528,634 | 1.32 | Reduce 14.19% | 0.23 | $130.38 | $720,824,000 | SEC |
| 2018 Q4 | 6,442,798 | 1.62 | Reduce 47.52% | 1.27 | $124.45 | $801,806,000 | SEC |
| 2018 Q3 | 12,277,114 | 2.68 | Reduce 18.38% | 0.46 | $139.12 | $1,707,992,000 | SEC |
| 2018 Q2 | 15,042,474 | 2.49 | Reduce 10.51% | 0.29 | $102.60 | $1,543,358,000 | SEC |
| 2018 Q1 | 16,808,283 | 2.76 | Add 1.79% | 0.05 | $97.00 | $1,630,403,000 | SEC |
| 2017 Q4 | 16,512,145 | 2.40 | Add 15.70% | 0.33 | $87.84 | $1,450,427,000 | SEC |
| 2017 Q3 | 14,271,640 | 1.94 | Add 20.16% | 0.33 | $79.59 | $1,135,880,000 | SEC |
| 2017 Q2 | 11,876,853 | 1.89 | Reduce 2.76% | 0.06 | $87.20 | $1,035,662,000 | SEC |
| 2017 Q1 | 12,214,476 | 2.01 | Add 0.87% | 0.02 | $88.99 | $1,086,966,000 | SEC |
| 2016 Q4 | 12,109,159 | 1.75 | Add 138.04% | 1.01 | $74.02 | $896,320,000 | SEC |
| 2016 Q3 | 5,086,931 | 0.77 | Add 651.74% | 0.67 | $75.63 | $384,724,000 | SEC |
| 2016 Q2 | 676,692 | 0.11 | Reduce 3.68% | <0.01 | $77.01 | $52,112,000 | SEC |
| 2016 Q1 | 702,541 | 0.10 | Buy | 0.10 | $78.05 | $54,834,000 | SEC |